BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
10 results:

  • 1. RNA-Interference-Mediated miR-122-Based Gene Regulation in Colon cancer, a Structural In Silico Analysis.
    Ganesan H; Nandy SK; Banerjee A; Pathak S; Zhang H; Sun XF
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499586
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of colorectal cancer].
    Gurer T; Aytekin A; Caki E; Gezici S
    Mol Biol (Mosk); 2022; 56(3):516-520. PubMed ID: 35621109
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Whole Exome Sequencing of Ulcerative Colitis-associated colorectal cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer.
    Margalef P; Fernández-Majada V; Villanueva A; Garcia-Carbonell R; Iglesias M; López L; Martínez-Iniesta M; Villà-Freixa J; Mulero MC; Andreu M; Torres F; Mayo MW; Bigas A; Espinosa L
    Cell Rep; 2012 Oct; 2(4):840-54. PubMed ID: 23041317
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/smrt corepressor complex dissociation/reassembly.
    Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
    Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3.
    Pendás-Franco N; García JM; Peña C; Valle N; Pálmer HG; Heinäniemi M; Carlberg C; Jiménez B; Bonilla F; Muñoz A; González-Sancho JM
    Oncogene; 2008 Jul; 27(32):4467-77. PubMed ID: 18408752
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Aberrant cytoplasmic localization of N-CoR in colorectal tumors.
    Fernández-Majada V; Pujadas J; Vilardell F; Capella G; Mayo MW; Bigas A; Espinosa L
    Cell Cycle; 2007 Jul; 6(14):1748-52. PubMed ID: 17630505
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer.
    Fernández-Majada V; Aguilera C; Villanueva A; Vilardell F; Robert-Moreno A; Aytés A; Real FX; Capella G; Mayo MW; Espinosa L; Bigas A
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):276-81. PubMed ID: 17190815
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo.
    Cao ZA; Bass KE; Balasubramanian S; Liu L; Schultz B; Verner E; Dai Y; Molina RA; Davis JR; Misialek S; Sendzik M; Orr CJ; Leung L; Callan O; Young P; Dalrymple SA; Buggy JJ
    Mol Cancer Ther; 2006 Jul; 5(7):1693-701. PubMed ID: 16891455
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
    Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S
    Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.